Richard Rodgers

Mr. Richard J.
Rodgers is an Independent Director at Novavax, Inc., an Independent Director at Opus Genetics, Inc. and an Independent Director at Ardelyx, Inc. He is on the Board of Directors at Novavax, Inc., Opus Genetics, Inc. and Ardelyx, Inc. Mr. Rodgers was previously employed as an Independent Director by Sagimet Biosciences, Inc., an Independent Director by Rexahn Pharmaceuticals, Inc., a CFO, Secretary, Treasurer & Executive VP by Tesaro, Inc., a Chief Financial Officer & Senior Vice President by Abraxis BioScience, Inc., a Chief Accounting Officer, Senior VP & Controller by MGI PHARMA, Inc., a Controller by MedSource Technologies Holdings LLC, a Principal by ADC Telecommunications, Inc., and a Principal by Arthur Andersen LLP.
He received his undergraduate degree from St. Cloud State University and an MBA from The Curtis L.
Carlson School of Management.